Sai Life Sciences to unveil new R&D facility in Sept 2026

The investment is part of the company’s planned capital expenditure, reflecting strong business momentum, a robust late-stage development pipeline, and increasing demand for scalable capacity across CMC development and manufacturing.

Leave a Reply

Your email address will not be published. Required fields are marked *